These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25493427)

  • 41. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder.
    Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Walker SJ; Mickey BJ; Koeppe RA; Langenecker SA; Zubieta JK
    Mol Psychiatry; 2015 Feb; 20(2):193-200. PubMed ID: 25600108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography.
    Akkus F; Ametamey SM; Treyer V; Burger C; Johayem A; Umbricht D; Gomez Mancilla B; Sovago J; Buck A; Hasler G
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):737-42. PubMed ID: 23248277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amphetamine induced endogenous opioid release in the human brain detected with [¹¹C]carfentanil PET: replication in an independent cohort.
    Mick I; Myers J; Stokes PR; Erritzoe D; Colasanti A; Bowden-Jones H; Clark L; Gunn RN; Rabiner EA; Searle GE; Waldman AD; Parkin MC; Brailsford AD; Nutt DJ; Lingford-Hughes AR
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):2069-74. PubMed ID: 24807268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The implication of salience network abnormalities in young male adult smokers.
    Li Y; Yuan K; Guan Y; Cheng J; Bi Y; Shi S; Xue T; Lu X; Qin W; Yu D; Tian J
    Brain Imaging Behav; 2017 Aug; 11(4):943-953. PubMed ID: 27437925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals.
    Turton S; Myers JF; Mick I; Colasanti A; Venkataraman A; Durant C; Waldman A; Brailsford A; Parkin MC; Dawe G; Rabiner EA; Gunn RN; Lightman SL; Nutt DJ; Lingford-Hughes A
    Mol Psychiatry; 2020 Aug; 25(8):1749-1758. PubMed ID: 29942043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Relationship of Varenicline Agonism of α4β2 Nicotinic Acetylcholine Receptors and Nicotine-Induced Dopamine Release in Nicotine-Dependent Humans.
    McCaul ME; Wand GS; Kuwabara H; Dannals RF; Wong D; Xu X
    Nicotine Tob Res; 2020 May; 22(6):892-899. PubMed ID: 31096265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).
    Bencherif B; Fuchs PN; Sheth R; Dannals RF; Campbell JN; Frost JJ
    Pain; 2002 Oct; 99(3):589-598. PubMed ID: 12406535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced mu opioid receptor availability in schizophrenia revealed with [
    Ashok AH; Myers J; Reis Marques T; Rabiner EA; Howes OD
    Nat Commun; 2019 Oct; 10(1):4493. PubMed ID: 31582737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between nicotine dependence scores and biomarkers of exposure in adult cigarette smokers.
    Muhammad-Kah RS; Hayden AD; Liang Q; Frost-Pineda K; Sarkar M
    Regul Toxicol Pharmacol; 2011 Jun; 60(1):79-83. PubMed ID: 21342662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood.
    Perkins KA; Lerman C; Grottenthaler A; Ciccocioppo MM; Milanak M; Conklin CA; Bergen AW; Benowitz NL
    Behav Pharmacol; 2008 Sep; 19(5-6):641-9. PubMed ID: 18690118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino ML; Dannals RF; Frost JJ
    Psychopharmacology (Berl); 2008 Nov; 200(4):475-86. PubMed ID: 18762918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse.
    Fehr C; Yakushev I; Hohmann N; Buchholz HG; Landvogt C; Deckers H; Eberhardt A; Kläger M; Smolka MN; Scheurich A; Dielentheis T; Schmidt LG; Rösch F; Bartenstein P; Gründer G; Schreckenberger M
    Am J Psychiatry; 2008 Apr; 165(4):507-14. PubMed ID: 18316420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.
    Johansson J; Hirvonen J; Lovró Z; Ekblad L; Kaasinen V; Rajasilta O; Helin S; Tuisku J; Sirén S; Pennanen M; Agrawal A; Crystal R; Vainio PJ; Alho H; Scheinin M
    Neuropsychopharmacology; 2019 Aug; 44(9):1667-1673. PubMed ID: 30867551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain regions related to tool use and action knowledge reflect nicotine dependence.
    Yalachkov Y; Kaiser J; Naumer MJ
    J Neurosci; 2009 Apr; 29(15):4922-9. PubMed ID: 19369561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil.
    Heinz A; Reimold M; Wrase J; Hermann D; Croissant B; Mundle G; Dohmen BM; Braus DF; Schumann G; Machulla HJ; Bares R; Mann K
    Arch Gen Psychiatry; 2005 Jan; 62(1):57-64. PubMed ID: 15630073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endogenous Opioid Mechanisms Are Implicated in Obesity and Weight Loss in Humans.
    Burghardt PR; Rothberg AE; Dykhuis KE; Burant CF; Zubieta JK
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3193-201. PubMed ID: 26108093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sex-specific differences in GABA(A) -benzodiazepine receptor availability: relationship with sensitivity to pain and tobacco smoking craving.
    Esterlis I; McKee SA; Kirk K; Lee D; Bois F; Stiklus SM; Seibyl JP; Krishnan-Sarin S; O'Malley SS; Staley JK; Cosgrove KP
    Addict Biol; 2013 Mar; 18(2):370-8. PubMed ID: 22353491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebral monoamine oxidase A inhibition in tobacco smokers confirmed with PET and [11C]befloxatone.
    Leroy C; Bragulat V; Berlin I; Grégoire MC; Bottlaender M; Roumenov D; Dollé F; Bourgeois S; Penttilä J; Artiges E; Martinot JL; Trichard C
    J Clin Psychopharmacol; 2009 Feb; 29(1):86-8. PubMed ID: 19142115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adolescent nicotine or cigarette smoke exposure changes subsequent response to nicotine conditioned place preference and self-administration.
    de la Peña JB; Ahsan HM; Botanas CJ; Sohn A; Yu GY; Cheong JH
    Behav Brain Res; 2014 Oct; 272():156-64. PubMed ID: 24991754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.